Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Saar Gill

Showing results (41-50 of 92) with videos related to

Pageof 10
Sort By:
Blood|March 18, 2010
NK cells mediate reduction of GVHD by inhibiting activated, alloreactive T cells while retaining GVT effectsJanelle A Olson, Dennis B Leveson-Gower, Saar Gill, et al.
Clinical Pharmacology and Therapeutics|February 17, 2019
Bispecific Antibodies in the Treatment of Hematologic MalignanciesJohannes Duell, Philip E Lammers, Ivana Djuretic, et al.
Clinical Lymphoma & Myeloma|July 25, 2008
[18F]fluorodeoxyglucose positron emission tomography scanning for staging, response assessment, and disease surveillance in patients with mantle cell lymphomaSaar Gill, Max Wolf, H Miles Prince, et al.
Transplantation and Cellular Therapy|September 4, 2022
Nomenclature for Cellular and Genetic Therapies: A Need for StandardizationAkshay Sharma, Stephanie Farnia, Folashade Otegbeye, et al.
Molecular Therapy. Oncology|June 24, 2024
Deletion of CD38 enhances CD19 chimeric antigen receptor T cell functionKimberly Veliz, Feng Shen, Olga Shestova, et al.
Annals of Hematology|April 11, 2008
Prolonged haematological toxicity from the hyper-CVAD regimen: manifestations, frequency, and natural history in a cohort of 125 consecutive patientsSaar Gill, Steven W Lane, Julie Crawford, et al.
Cancer Discovery|June 4, 2017
Overcoming the Immunosuppressive Tumor Microenvironment of Hodgkin Lymphoma Using Chimeric Antigen Receptor T CellsMarco Ruella, Michael Klichinsky, Saad S Kenderian, et al.
Proteomics|January 25, 2017
Improved surfaceome coverage with a label-free nonaffinity-purified workflowTina Glisovic-Aplenc, Saar Gill, Lynn A Spruce, et al.
British Journal of Haematology|August 22, 2009
Mantle cell lymphoma with central nervous system involvement: frequency and clinical featuresSaar Gill, Kirsten E Herbert, H Miles Prince, et al.
The New England Journal of Medicine|April 29, 2026
CD19 CAR T-Cell Therapy for Treatment of Chronic Graft-versus-Host DiseaseKaramjeet S Sandhu, Jessica Cheng, Patrick W Mellors, et al.
Pageof 10

Showing results (41-50 of 92) with videos related to

Sort By:
Pageof 10
Blood|March 18, 2010
NK cells mediate reduction of GVHD by inhibiting activated, alloreactive T cells while retaining GVT effectsJanelle A Olson, Dennis B Leveson-Gower, Saar Gill, et al.
Clinical Pharmacology and Therapeutics|February 17, 2019
Bispecific Antibodies in the Treatment of Hematologic MalignanciesJohannes Duell, Philip E Lammers, Ivana Djuretic, et al.
Clinical Lymphoma & Myeloma|July 25, 2008
[18F]fluorodeoxyglucose positron emission tomography scanning for staging, response assessment, and disease surveillance in patients with mantle cell lymphomaSaar Gill, Max Wolf, H Miles Prince, et al.
Transplantation and Cellular Therapy|September 4, 2022
Nomenclature for Cellular and Genetic Therapies: A Need for StandardizationAkshay Sharma, Stephanie Farnia, Folashade Otegbeye, et al.
Molecular Therapy. Oncology|June 24, 2024
Deletion of CD38 enhances CD19 chimeric antigen receptor T cell functionKimberly Veliz, Feng Shen, Olga Shestova, et al.
Annals of Hematology|April 11, 2008
Prolonged haematological toxicity from the hyper-CVAD regimen: manifestations, frequency, and natural history in a cohort of 125 consecutive patientsSaar Gill, Steven W Lane, Julie Crawford, et al.
Cancer Discovery|June 4, 2017
Overcoming the Immunosuppressive Tumor Microenvironment of Hodgkin Lymphoma Using Chimeric Antigen Receptor T CellsMarco Ruella, Michael Klichinsky, Saad S Kenderian, et al.
Proteomics|January 25, 2017
Improved surfaceome coverage with a label-free nonaffinity-purified workflowTina Glisovic-Aplenc, Saar Gill, Lynn A Spruce, et al.
British Journal of Haematology|August 22, 2009
Mantle cell lymphoma with central nervous system involvement: frequency and clinical featuresSaar Gill, Kirsten E Herbert, H Miles Prince, et al.
The New England Journal of Medicine|April 29, 2026
CD19 CAR T-Cell Therapy for Treatment of Chronic Graft-versus-Host DiseaseKaramjeet S Sandhu, Jessica Cheng, Patrick W Mellors, et al.
Pageof 10